After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Editas Medicine Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Editas Medicine Inc is $454.05M. A total of 1.71 million shares were traded on the day, compared to an average of 1.89M shares.
In the most recent transaction, O’Neill Gilmore Neil sold 77,824 shares of EDIT for 9.42 per share on Mar 05 ’24. After the transaction, the CEO now owns 327,470 company shares. In a previous transaction on Mar 04 ’24, Mei Baisong sold 20,327 shares at 9.42 per share. EDIT shares that SVP, CHIEF MEDICAL OFFICER owns now total 141,543.
Among the insiders who sold shares, Eaton Bruce disposed of 103 shares on Dec 05 ’23 at a per-share price of $10.90. This resulted in the EVP, CBO AND CTO holding 74,791 shares of EDIT after the transaction. In another insider transaction, Eaton Bruce sold 695 shares at $8.21 per share on Nov 14 ’23. Company shares held by the EVP, CBO AND CTO now total 74,894.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, EDIT has a high of $11.91 and a low of $5.60.
As of this writing, EDIT has an earnings estimate of $Editas Medicine, Inc. per share for the current quarter. EPS was calculated based on a consensus of EDUT estimates, with a high estimate of $FINDIT INC per share and a lower estimate of $EDITAS MEDICINE DL-,0001.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. EDIT’s latest balance sheet shows that the firm has $499.85M in Cash & Short Term Investments as of fiscal 2021. There were $26.38M in debt and $46.88M in liabilities at the time. Its Book Value Per Share was $4.27, while its Total Shareholder’s Equity was $553.64M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EDIT is Buy with a score of 3.88.
